BioLeaders

Tim Sparey BioLeaders Interview - Tim Sparey (February 2020)   CEO of Novintum; lives in North London; education: PhD in Chemistry; Hobbies: sports, wine and eating out. I am a medicinal chemist by background, with 25 years spent in large pharma and biotech has helped build companies in multiple disease areas including cancer, CNS, inflammation and ophthalmology. My track record of licensing, fundraising and exits, in private and public companies, has included Proximagen (CBO), Q Chip (CEO), Midatech (CBO) and Novintum Bioscience (CEO & co-founder). I also advise and chair several companies in the areas of AI/machine learning, automation technologies [...]

Martin Hunt BioLeaders Interview – Martin Hunt (February 2020) I have 30 years’ experience in the life science industry has spanned executive and NED roles in multi-nationals, SMEs and public companies. During 15 years in international Medtech companies, I had senior roles in sectors including ophthalmic surgery, wound management and chronic care. I joined Tissue Science Laboratories (TSL) as Chief Executive in 1999 and led the company from angel funding as a start-up, to a listing on the AiM market in 2001 through to trade sale to Covidien in 2008. Since then, I have pursued a portfolio career, including [...]

Keith Thompson BioLeaders Interview – Keith Thompson (January 2020) I am the CEO of the Cell and Gene Therapy Catapult, which I started in 2012 and from which will be retiring in April 2020. At various times MD of Bioscot Scotland’s first Biotech company, VP of NASDAQ listed Serologicals, National Director of SNBTS, several industry/association Boards including BIA, ARM, IPFA, EBA; age 62; married to Helen for 40 years with 2 grown up children; Born near Liverpool but lived most of adult life in (and travelled the world from) Edinburgh moving to London to set up the Catapult; education: [...]

Kevin Lin BioLeaders Interview – Kevin Lin (December 2019) CEO, TusPark UK; lives in Cambridge; education: Master of Public Management, Hobbies: collecting traditional Chinese furniture. Key milestones in your career journey to date? Joined the financial sector in China; initially as a management trainee with a commercial bank; followed by a Trust Company where I learnt how to identify and fund successful investments; these experiences gave me great oversight of the complexity of the financial sector; and prepared me well for TusPark, which is all about value creation. Who has had the greatest influence over your career? My current boss [...]

Kate Bingham BioLeaders Interview – Kate Bingham (November 2019) Managing Partner at SV Health Investors; married to Jesse Norman, Minister for Tax (as at the time of writing), 3 grown up children; most demanding hobby- mountain bike bog snorkelling! Key milestones in your career journey to date? I’ve somehow managed to be in the right place at the right time; significantly, talked myself into an intern role at Vertex in 1990 which inspired my passion for the sector; and the opportunity to help launch the new life science practice for SV (then Schroder Ventures) in the early 90s [...]

Mark Treherne BioLeaders Interview – Mark Treherne (November 2019) Mark has over 25 years’ experience in the discovery of novel treatments for diseases with unmet medical need. he formerly worked at Pfizer where he was responsible for research into neurodegenerative diseases. Mark then set up Cambridge Drug Discovery as Chief Executive, which was sold to BioFocus (now part of Charles River). Since then, Mark has worked with many early-stage biotechnology companies from foundation through to trade sale.‎ More recently, he was Chief Executive of the Life Sciences Organisation of UK Trade & Investment, which helped UK-based Life Sciences companies [...]

Peter Pack BioLeaders Interview – Peter Pack (October 2019) Trained as a Chemist and Molecular Biologist, I have been CEO for several companies over the past 20 years, helping to start, build and exit life science companies in Germany and the UK. I have worked in the biotech industry since 1992 when I started as one of the first employees of Morphosys which was founded by my PhD mentor Andreas Pluecktun and Simon Moroney (who came from the UK) in that year. I recently stepped down as CEO of Crescendo Biologics in Cambridge, where I lived and worked for [...]

Ros Deegan BioLeaders Interview – Ros Deegan (October 2019) CEO OMass Therapeutics in Oxford. Has lived in Belgium, France, US and UK. Studied at Cambridge University and INSEAD. Likes to explore both the physical world with her husband, and the scientific world with her company. Key milestones in your career journey to date? Moving into the biotech world in 2008, travelling between countries – working in the US in 1999 and again 2006 – 2019; first SVP role and IPO at Trevena in 2013/14; first CEO role at OMass in 2019. Who has had the greatest influence over your [...]

David Roblin BioLeaders Interview – David Roblin (October 2019) President of R&D and COO of Summit Therapeutics PLC, Chair of Scientific Translation at The Crick, NED at SoseiHeptares PLC, various grant committees at Wellcome and LEO Foundation; age 53; married with 3 children; Welshman of Kent; education: comprehensively near Swansea, then UCL and St George’s; Hobbies: travelling extensively with my family – Namibia in 2019. Key milestones in your career journey to date? Leaving the land of my fathers (Wales) in 1985; meeting my wife, Sally, at medical school in 1987; my career went from bedside to bench and [...]